Vivani Medical, Inc.
News
Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant
Business Wire Vivani Medical, Inc. (Nasdaq: VANI) (Vivani or the Company), an innovative biopharmaceutical company developing miniature, ultra long-acting, subdermal drug implants, today reported positive...\n more…
EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity
Benzinga Vivani Medical reports promising preclinical liver fat reduction results with its exenatide implant for obesity, showing potential as a differentiated treatment option. The LIBERATE-1 clinical trial is set to begin in Q4 2024.\n more…
Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Business Wire Vivani Medical, Inc. (Nasdaq: VANI) (Vivani or the Company), an innovative biopharmaceutical company developing miniature, ultra long-acting, subdermal drug implants, today announced its plans to...\n more…
Contrasting Vivani Medical (NASDAQ:VANI) and Pixie Dust Technologies (NASDAQ:PXDT)
Ticker Report Vivani Medical (NASDAQ:VANI - Get Free Report) and Pixie Dust Technologies (NASDAQ:PXDT - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the...\n more…
We Think Vivani Medical (NASDAQ:VANI) Needs To Drive Business Growth Carefully
Simply Wall St Just because a business does not make any money, does not mean that the stock will go down. For example, although...\n more…
VANI Stock Earnings: Vivani Medical Beats EPS for Q2 2024
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nVANI stock results show that Vivani Medical beat analyst estimates for earnings per share the second quarter of 2024.\nThe post VANI...\n more…